VECTORMUNE HVT NDV& RISPENS (LIVE, FROZEN VACCINE)

Indications

• Cryopreservation of sperm
• Cryopreservation of oocytes
• Cryopreservation of embryos
• Cryopreservation of stem cells
• Cryopreservation of tissues and organs for transplantation

Dosage

Children: Refer to specific guidelines for cryoprotectant concentrations and protocols based on the type of biological material and the specific cryoprotectant used.

Adults: Refer to specific guidelines for cryoprotectant concentrations and protocols based on the type of biological material and the specific cryoprotectant used.

Mechanism of action

Cryoprotectants function primarily by replacing water in biological systems, thereby reducing ice formation during the freezing process. Specific cryoprotectants, such as glycerol and dimethyl sulfoxide (DMSO), penetrate the cell membrane and interact with cellular components, stabilizing proteins and membranes. This interaction helps maintain cellular integrity during the freezing and thawing cycles.

Pharmacodynamics

Cryoprotectants enhance the viability of cells after thawing by preventing ice crystal formation, which can cause mechanical damage. They also help to reduce osmotic stress and maintain the osmotic balance of cells during the cryopreservation process. The effectiveness of cryoprotectants is influenced by their concentration, the cooling rate, and the specific type of cells or tissues being preserved.

Pharmacokinetics

Cryoprotectants are typically administered in a controlled manner during the cryopreservation process. Their distribution and penetration into cells depend on their molecular weight, hydrophilicity, and the presence of any protective agents. The elimination of cryoprotectants occurs mainly through cellular metabolism and dilution during thawing. The specific pharmacokinetics can vary depending on the cryoprotectant used.

Pregnancy

The safety of cryoprotectants during pregnancy has not been well established. They should be used only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether cryoprotectants are excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Cryoprotectants should be stored at room temperature, away from light and moisture. Specific storage conditions may vary depending on the particular cryoprotectant.

Dosage

Children: Refer to specific medications used to treat the particular disease for dosing information.

Adults: Refer to specific medications used to treat the particular disease for dosing information.

Mechanism of action

The mechanism of action varies significantly depending on the specific disease in question. For infectious diseases, pathogens may interact with host cells, leading to inflammation, immune response activation, or tissue damage. Chronic diseases often involve complex interactions between genetic factors, lifestyle choices, and environmental influences. For example, in autoimmune diseases, the immune system mistakenly targets healthy cells, leading to inflammation and tissue destruction.

Pharmacodynamics

Pharmacodynamics of disease involves understanding how the disease state affects physiological functions and the body's response to treatment. In infectious diseases, the presence of pathogens can lead to altered immune responses, while chronic diseases may involve changes in metabolic pathways, hormonal balances, or cellular functions. Medications targeting disease processes aim to restore normal function, alleviate symptoms, or eradicate pathogens.

Pharmacokinetics

Pharmacokinetics is not applicable to the term 'disease' as it refers to the movement of drugs within the body, including absorption, distribution, metabolism, and excretion of specific medications used to treat diseases. Each medication will have its own pharmacokinetic profile depending on its chemical properties and the disease being treated.

Indications

• Rheumatoid arthritis
• Juvenile idiopathic arthritis
• Psoriatic arthritis
• Ankylosing spondylitis

Dosage

Children: Refer to the BNF for Children for accurate dosing information based on individual patient needs.

Adults: Refer to specific clinical guidelines or the BNF for accurate dosing information based on individual patient needs.

Mechanism of action

Rheumatoid arthritis therapy often involves the use of disease-modifying antirheumatic drugs (DMARDs), nonsteroidal anti-inflammatory drugs (NSAIDs), and biological agents. These agents work by targeting specific pathways in the inflammatory process, such as inhibiting cytokine production or blocking the activity of immune cells involved in the inflammatory response.

Pharmacodynamics

The pharmacodynamics of drugs used in the treatment of rheumatoid arthritis typically involves the reduction of inflammation in the joints, improvement of physical function, and prevention of joint damage. This is achieved through various mechanisms, including modulation of immune responses and inhibition of inflammatory mediators.

Pharmacokinetics

The pharmacokinetics of rheumatoid arthritis medications can vary widely depending on the specific drug used. Generally, these medications are absorbed through the gastrointestinal tract, metabolized in the liver, and excreted primarily via the kidneys. The half-life can also vary, influencing dosing frequency and duration of action.

Pregnancy

There is limited data on the use of rhvt in pregnant women. It is advisable to assess the risk versus benefit before prescribing.

Breast-feeding

There is insufficient information on the safety of rhvt during breastfeeding. Caution is recommended.

Storage

Store rhvt in a cool, dry place away from direct sunlight. Ensure it is kept out of reach of children.

Indications

• Schizophrenia
• Bipolar disorder
• Irritability associated with autism

Dosage

Children: Refer to the BNF for Children for appropriate dosage guidelines tailored to pediatric patients.

Adults: Refer to the BNF for specific dosage details based on individual patient needs and conditions.

Mechanism of action

Risperidone exerts its antipsychotic effects by acting as an antagonist at dopamine D2 receptors and serotonin 5-HT2A receptors. This dual action is believed to contribute to its efficacy in managing symptoms of schizophrenia and other mood disorders. By blocking these receptors, risperidone helps to balance neurotransmitter activity, reducing psychotic symptoms and stabilizing mood.

Pharmacodynamics

The pharmacodynamic profile of risperidone includes its efficacy in reducing both positive symptoms (such as hallucinations and delusions) and negative symptoms (such as emotional flatness and social withdrawal) of schizophrenia. The drug also has anxiolytic and mood-stabilizing properties. The onset of action can vary, with improvement in symptoms typically observed within a few weeks of therapy.

Pharmacokinetics

Risperidone is absorbed well after oral administration, with peak plasma concentrations occurring approximately 1 to 2 hours post-dose. It is extensively metabolized in the liver, primarily by cytochrome P450 2D6, to its active metabolite, 9-hydroxyrisperidone. The elimination half-life of risperidone is approximately 20 hours, while that of its metabolite is about 30 hours. Excretion occurs mainly through urine, with a small amount eliminated in feces.

Contra-indications

• Hypersensitivity to risperidone or any of its components
• Severe central nervous system depression
• Comatose states
• Parkinson's disease
• Dementia-related psychosis in elderly patients

Adverse effects

• Extrapyramidal symptoms
• Sedation
• Weight gain
• Metabolic syndrome
• Hyperglycemia
• Hyperlipidemia
• Neuroleptic malignant syndrome
• Tardive dyskinesia
• Agranulocytosis
• Orthostatic hypotension

Interactions

• Caution with other CNS depressants, including alcohol
• May enhance the effects of antihypertensive agents
• Increased risk of serotonin syndrome with SSRIs or other serotonergic drugs
• May interact with drugs that affect CYP2D6 metabolism

Precautions

• Monitor for signs of extrapyramidal symptoms
• Use with caution in patients with cardiovascular disease
• Regularly monitor metabolic parameters such as weight and glucose levels
• Caution in patients with a history of seizures

Pregnancy

Risperidone should only be used in pregnancy if the potential benefit justifies the potential risk to the fetus. Limited data suggests potential risks, including congenital malformations.

Breast-feeding

Risperidone is excreted in breast milk. Caution is advised when administering to nursing mothers as it may affect the infant.

Storage

Store at room temperature, away from moisture and light. Keep out of reach of children.

Formulations

• Tablets
• Oral solution
• Injectable forms (for long-acting administration)

Indications

• Bacterial infections
• Viral infections
• Epidemiological studies
• Antibiotic resistance monitoring

Dosage

Children: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Adults: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Mechanism of action

The mechanism of action for a strain depends on the type of microorganism it represents. For pathogenic bacteria, the strain may produce toxins, evade the host's immune response, or possess resistance mechanisms that allow it to survive in the presence of antibiotics. For viruses, strains may exhibit mutations that alter their ability to infect host cells or evade antiviral therapies.

Pharmacodynamics

Pharmacodynamics in the context of strains involves the interaction between the strain and the host's immune system, as well as the effects of specific antimicrobial agents on the strain. These interactions can influence the efficacy of treatments and the development of resistance.

Pharmacokinetics

Pharmacokinetics is not directly applicable to strains themselves but rather to the drugs used to treat infections caused by specific strains. Factors such as absorption, distribution, metabolism, and excretion of antimicrobial agents can vary depending on the strain's characteristics and the site of infection.

Pregnancy

There is limited information on the safety of strain in pregnancy. It is advisable to consult healthcare professionals for guidance.

Breast-feeding

Safety during breastfeeding is not well established. It is recommended to seek medical advice before use.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Indications

• Muscle strain
• Tendon strain
• Acute pain management
• Inflammation control

Dosage

Children: Refer to specific medication guidelines as dosing varies by drug used for pain management.

Adults: Refer to specific medication guidelines as dosing varies by drug used for pain management.

Mechanism of action

The mechanism of injury in strains involves the disruption of muscle fibers or tendons due to excessive tension or force. This can lead to inflammation, pain, and impaired function. Inflammatory mediators are released at the site of injury, resulting in local vasodilation, increased permeability of blood vessels, and recruitment of immune cells which contribute to the healing process.

Pharmacodynamics

The pharmacodynamics of treating strains often involve the use of analgesics and anti-inflammatory medications, which work by inhibiting cyclooxygenase (COX) enzymes, leading to decreased production of prostaglandins. This reduces pain and inflammation associated with muscle or tendon injury. Physical therapy may also play a significant role in enhancing recovery and restoring function.

Pharmacokinetics

The pharmacokinetics of medications used for strains, such as NSAIDs, vary depending on the specific drug. Generally, these agents are absorbed rapidly from the gastrointestinal tract, peak in plasma concentration within a few hours, and have a half-life that varies widely. Metabolism typically occurs in the liver, and excretion is primarily via the kidneys. Individual responses can vary based on age, weight, and overall health.

Pregnancy

Consult healthcare provider before use.

Breast-feeding

Consult healthcare provider before use.

Storage

Store in a cool, dry place, away from direct sunlight.